biomarker discovery Dec 1, 2022 Nectin Therapeutics Enters Clinical Stage With Drug for Non-Responders to Checkpoint Inhibitors Premium Nov 23, 2022 Higher TIL Levels in Residual Disease May Predict Worse Survival in HER2-Positive Breast Cancer Premium Nov 15, 2022 Owkin, Stanford Medicine Collaborate on AI-Driven Lung Cancer, Mesothelioma Biomarker Discovery Oct 17, 2022 Singapore Institutions Launch Program to Diagnose, Treat EBV-Associated Nasopharyngeal Cancer Oct 13, 2022 Tavros Therapeutics, Bayer Subsidiary Vividion Ink Precision Oncology Deal Oct 11, 2022 ONI, UPenn Partner on Microscopy-Based CAR T-Cell Therapy Biomarker Research Oct 7, 2022 Swiss Biotech PreComb Therapeutics Wants to Automate Functional Precision Medicine Premium Sep 29, 2022 New NIH-Funded Network Aims to Bring Precision to External Beam Radiation Treatment Premium Sep 27, 2022 Tavros Therapeutics Raises $7.5M to Advance Biomarker-Directed Cancer Drug Discovery Platform Sep 20, 2022 Transcriptomics Plus 'Immune Tolerance' of Normal Tissue Shows Promise in Lung Cancer Prognosis Premium Sep 16, 2022 Biocytogen Pharmaceuticals, Guangzhou FineImmune Biotechnology Ink Cell Therapy Partnership Sep 13, 2022 Imaging Agent May Have Potential as Noninvasive Test to Predict PARP Inhibitor Response Sep 7, 2022 Head and Neck Cancer Treatment Targets, Biomarkers Unearthed in Cell Model Analyses Sep 1, 2022 Multiple Myeloma Researchers Chip Away at Why Some Patients Relapse Quickly After CAR T-Cell Therapy Premium Jul 11, 2022 Immune Checkpoint Blockade Response Linked to Recurrent Mutations in Genes, Pathways Jun 30, 2022 Analysis of Tumor Mutation, Treatment Data Across Cancers Points to Predictive Biomarkers Jun 5, 2022 Biomarkers May Identify Ovarian Cancer Patients Who Benefit From AstraZeneca WEE1 Inhibitor May 26, 2022 TIGIT Blockade Could Be Key to Improving Success Rates in CAR T-Cell Therapy Premium May 2, 2022 Ikena Oncology, Vall d'Hebron Institute Partner on Biomarker Research Apr 28, 2022 Owkin, ADC Therapeutics Team on AI-Based Biomarker Discovery Load More Breaking News Flare Therapeutics Raises $123M in Oversubscribed Series B Funding Round William Blair Initiates Coverage of MDxHealth With Outperform Rating White House Report Outlines Goals to Advance Genomic Research, Precision Therapy Development In Brief This Week: Fore Biotherapeutics, RayzeBio, Gilead Sciences, Atossa Therapeutics Bayer to Assess Nubeqa in High-Risk, Early-Stage Hormone-Sensitive Prostate Cancer BridgeBio Begins Phase I/II Study of SHP2 Inhibitor, Opdivo in KRAS-Mutant Solid Tumors
